Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2019 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly Exchange Rate Effect of -$1.3 million in Q1 2026, down 211.76% quarter-over-quarter from -$408000.0 in Q4 2025, and down 220.57% on a YoY basis from $1.1 million in Q1 2025.
Mirum Pharmaceuticals (MIRM) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 220.57% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at $895000.0 (up 352.11% YoY), while the FY2025 annual figure was $3.2 million, up 348.42% from the prior year.
- Exchange Rate Effect was -$1.3 million for Q1 2026 at Mirum Pharmaceuticals, down from -$408000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.2 million in Q2 2025 to a low of -$1.4 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $31294.1 across 5 years, with a median of -$3000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect sank 1733.33% in 2022, then soared 6366.67% in 2023.
- A 5-year view of Exchange Rate Effect shows it stood at $85000.0 in 2022, then grew by 27.06% to $108000.0 in 2023, then slumped by 1376.85% to -$1.4 million in 2024, then surged by 70.41% to -$408000.0 in 2025, then slumped by 211.76% to -$1.3 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.3 million (Q1 2026), -$408000.0 (Q4 2025), and $349000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn | -1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.27 Mn |
| Mar 31, 2026 | -1.27 Mn |
| Dec 31, 2025 | -408,000.00 |
| Dec 31, 2025 | -408,000.00 |
| Sep 30, 2025 | 349,000.00 |
| Sep 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | 88,000.00 |
| Sep 30, 2024 | 88,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |